Abstract:Background Osteoarthritis (OA) is a debilitating disease that inflicts intractable pain, a major problem that humanity faces, especially in aging populations. Stem cells have been used in the treatment of many chronic diseases, including OA. Cartilage progenitor/stem cells (CPSCs) are a type of stem cells with the ability to self- renew and differentiate. They hold a promising future for the understanding of the progression of OA and for its treatment. Previous studies have reported the relationship between mitochondrial dynamics and mesenchymal stem cell (MSC) proliferation, differentiation and aging. Mitochondrial dynamic and morphology change during stem cell differentiation. Methods This study was performed to access the relationship between mitochondrial dynamics and chondrogenic differentiation of CPSCs. Mitochondrial fusion and fission levels were measured during the chondrogenic differentiation process of CPSCs. After that, we used mitochondrial fusion promoter to induce fusion in CPSCs and then the chondrogenic markers were measured. Transmission electron microscopy (TEM) and confocal microscopy were used to capture the mass and fusion status of mitochondria. Lentiviruses were used to detect the role of mitofusin 2 ( Mfn2 ) in CPSC chondrogenic differentiation. In vivo, Mfn2 was over-expressed in sheets of rat CPSCs, which were then injected intra-articularly into the knees of rats. Results Mitochondrial fusion markers were upregulated during the chondrogenic induction process of CPSCs. The mass of mitochondria was higher in differentiated CPSC, and the fusion status was obvious relative to un-differentiated CPSC. Chondrogenesis of CPSCs was upregulated with the induction by mitochondrial fusion promoter. Mfn2 over-expression significantly increased chondrocyte-specific gene expression and reversed OA through NOTCH2 signal pathway. Conclusions Our study demonstrated that the mitochondrial fusion promotes chondrogenesis differentiation of CPSCs. Mfn2 accelerates the chondrogenesis differentiation of CPSCs through Notch2 . In vivo, Mfn2 -OE in sheets of rCPSCs ameliorated OA in the rat model.

From Dysfunction to Healing: Advances in Mitochondrial Therapy for Osteoarthritis

Mitochondria: Potential Targets for Osteoarthritis

Therapeutic and tampering approaches for mitochondrial associated diseases

Mitochondrial quality control dysfunction in osteoarthritis: Mechanisms, therapeutic strategies & future prospects

Advances in the study of mitophagy in osteoarthritis

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Mitochondrial dysfunction: mechanisms and advances in therapy

The Effect of Mitochondrial Fusion on Chondrogenic Differentiation of Cartilage Progenitor/stem Cells Via Notch2 Signal Pathway

Advances in Mesenchymal Stem Cell Therapy for Osteoarthritis: From Preclinical and Clinical Perspectives

The Role of Mitochondrial Metabolism, AMPK-SIRT Mediated Pathway, LncRNA and MicroRNA in Osteoarthritis

The Effect of Mitochondrial Fusion on Chondrogenic Differentiation of Cartilage Progenitor Cells via Notch2 Signal Pathway

The current insights of mitochondrial hormesis in the occurrence and treatment of bone and cartilage degeneration

Advances in Stem Cell-Based Therapies in the Treatment of Osteoarthritis

Research progress on role of energy metabolism in osteoarthritis

Mitochondrial dysfunction and therapeutic perspectives in osteoporosis

New insight of the pathogenesis in osteoarthritis: the intricate interplay of ferroptosis and autophagy mediated by mitophagy/chaperone-mediated autophagy

Retuning Mitochondrial Apoptosis/Mitophagy Balance via SIRT3‐energized And Microenvironment‐Modulated Hydrogel Microspheres to Impede Osteoarthritis

Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis

Exosome-Mediated Drug Delivery for Cell-Free Therapy of Osteoarthritis

Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents

Mitochondrial destabilization in tendinopathy and potential therapeutic strategies